Skip to main content
Fig. 4 | Acta Neuropathologica Communications

Fig. 4

From: Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis

Fig. 4

Surfen selectively reduces chemokine expression during EAE. a mRNA expression, b protein concentration for selected chemokines. CFA + PTX controls treated with vehicle (CFA-V) or surfen (CFA-S) are compared to EAE treated with vehicle (EAE-V) or surfen (EAE-S). Significance is shown as mean ± SEM; significant data are marked, comparing vehicle treated EAE with CFA-vehicle (# = P < 0.05) or between groups as indicated by cross bars (* = P < 0.05)

Back to article page

Acta Neuropathologica Communications

ISSN: 2051-5960

Contact us